Cargando…
Analysis on Clinical Outcomes of Low-Molecular Weight Heparin Combined with Magnesium Sulfate in Patients with Pre-Eclampsia
BACKGROUND: We aimed to investigate the clinical effect of low molecular weight heparin (LMWH) combined with magnesium sulfate in patients with severe pre-eclampsia (PE). METHODS: A total of 70 patients with severe PE admitted in Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medic...
Autores principales: | Wang, Ningning, Feng, Chun, Sun, Minghe, Pu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643237/ https://www.ncbi.nlm.nih.gov/pubmed/36407738 http://dx.doi.org/10.18502/ijph.v51i5.9422 |
Ejemplares similares
-
An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
por: Smith, Jeffrey Michael, et al.
Publicado: (2013) -
Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia
por: Padda, Jaskamal, et al.
Publicado: (2021) -
Health System Barriers to Access and Use of Magnesium Sulfate for Women with Severe Pre-Eclampsia and Eclampsia in Pakistan: Evidence for Policy and Practice
por: Bigdeli, Maryam, et al.
Publicado: (2013) -
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Effect of magnesium sulfate combined with labetalol on serum sFlt-1/PlGF ratio in patients with early-onset severe pre-eclampsia
por: Wang, Ying, et al.
Publicado: (2020)